Executive Summary
Miracle Systems LLC, a small disadvantaged business, captured a $224M GSA delivery order for CISA Program Management Support Services under full and open competition, delivering a strong bullish signal with upside to $271M including options. No funds outlayed yet delays revenue but exposes medium-term growth via options and potential extensions through 2026.
This sole record highlights SDB competitiveness in federal engineering services amid cybersecurity priorities.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal Professional Services Contracts digest from March 07, 2026.
Investment Signals (1)
- Miracle Systems Wins $224M CISA Support Contract (HIGH)▲
$224M obligation (potential $271M) time-and-materials award for 5-year engineering services signals multi-year revenue ramp-up for this SDB.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
$0 outlayed delays revenue recognition; 5-year term to 2026-09-26 vulnerable to mods/terminations.
- Regulatory [LOW RISK]▼
Time-and-materials structure invites cost audits and oversight.
Opportunities (1)
- ◆
$47M unexercised options plus follow-on potential post-2026 for CISA engineering services.
Sector Themes (1)
- ◆
Self-certified small disadvantaged business wins $224M full/open GSA award for CISA support under NAICS 541330.
Watch List (1)
- 👁
{"entity"=>"Miracle Systems LLC", "reason"=>"$224M award with $47M options but $0 outlayed signals pending revenue inflection.", "trigger"=>"First outlays or option funding"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal Professional Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals